Business Insider
My Markets Watchlist
Markets Stocks

Repro Medical System IncShs Stock , KRMD

3.23 +0.01 +0.31%
03:59:59 PM EDT 6/13/2025 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Friday 06/13/2025 the closing price of the Repro Medical System IncShs share was $3.22 on BTT. Compared to the opening price on Friday 06/13/2025 on BTT of $3.27, this is a drop of 1.55%. Repro Medical System IncShs's market capitalization is $120.92 M by 46.14 M shares outstanding.
Is Repro Medical System stock a Buy, Sell or Hold? Repro Medical System stock has received a consensus rating of buy. The average rating score is and is based on 3 buy ratings, 2 hold ratings, and 0 sell ratings.
What was the 52-week low for Repro Medical System stock? The low in the last 52 weeks of Repro Medical System stock was 1.87. According to the current price, Repro Medical System is 172.73% away from the 52-week low.
What was the 52-week high for Repro Medical System stock? The high in the last 52 weeks of Repro Medical System stock was 5.04. According to the current price, Repro Medical System is 64.09% away from the 52-week high.
What are analysts forecasts for Repro Medical System stock? The 5 analysts offering price forecasts for Repro Medical System have a median target of 3.60, with a high estimate of 4.50 and a low estimate of 3.00. The median estimate represents a 89.72 difference from the last price of 3.23.

Repro Medical System Stock Snapshot

2.82
Bid
100.00
Bid Size
3.73
Ask
100.00
Ask Size
6/13/2025
Date
3:59 PM
Time
4,148.00
Volume
3.22
Prev. Close
3.27
Open
149.04 M
Market Cap in USD
46.14 M
Number of Shares
46.14 M
Total Number of Shares
3.23
Day Low
3.30
Day High
3.23
1.87
52 Week Low
5.04
52 Week High
3.23
0.00
Dividend in USD
0.00
Dividend Yield
95.15
Free Float in %
-0.13
EPS in USD
0.37
Book Value per Share in USD
-0.01
Cash Flow per Share in USD

Historical Prices for Repro Medical System

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Repro Medical System Analyst Data

Total Analysts: 5
Buy Ratings: 3 Neutral Ratings: 2 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 3.00 Median: 3.60 Highest: 4.50
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Repro Medical System Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/08/25 Piper Sandler
Maintained Hold $3.5
02/14/25 Piper Sandler
Downgraded to Hold $4.5
12/07/23 Capital Depesche
Maintained Buy $3
09/07/23 Lake Street
Maintained Buy $4
08/03/23 Piper Sandler
Maintained Buy $3

Repro Medical System Estimates* in USD

  2025 2026 2027
Revenue 39 45 53
Dividend - - -
Dividend Yield (in %) - - -
EPS -0.07 -0.01 -
P/E Ratio -47.50 -323.00 54.67
EBIT -5 -2 0
EBITDA -1 2 5
Net Profit -4 -2 0
Net Profit Adjusted -3 -2 0
Pre-Tax Profit -5 -2 0
Pre-Tax Profit Reported - - -
EPS (Non-GAAP) ex. SOE -0.04 0.00 -
EPS (GAAP) -0.10 -0.04 0.01
Gross Income 24 28 33
Cash Flow from Investing -1 - -
Cash Flow from Operations 0 1 -
Cash Flow from Financing - - -
Cash Flow per Share - - -
Free Cash Flow -1 1 -
Free Cash Flow per Share - - -
Book Value per Share - - -
Net Debt - - -
Research & Development Exp. 5 6 5
Capital Expenditure 1 - -
Selling, General & Admin. Exp. 23 24 26
Shareholder’s Equity 16 15 -
Total Assets 27 28 -
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 5 5 5 5
Average Estimate - -0.022 USD -0.016 USD -0.068 USD -0.010 USD
Year Ago - -0.022 USD -0.035 USD -0.133 USD -
Publish Date - 8/6/2025 11/5/2025 - -
Revenue Estimates
No. of Analysts - 5 5 5 5
Average Estimate - 9 USD 10 USD 39 USD 45 USD
Year Ago - 8 USD 8 USD 34 USD -
Publish Date - 8/6/2025 11/5/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Sales 33.65 28.52 27.90 23.49 24.18 23.16 17.35
Change of sales in % 17.98 2.23 18.76 -2.84 4.38 33.47 8.62
Gross profit on sales 20.44 15.84 14.78 13.31 14.52 14.51 10.50
Gross profit on sales change in % 29.08 7.14 11.09 -8.34 0.03 38.21 11.03
Operating income -6.45 -10.27 -10.78 -7.03 1.29 4.00 1.16
Operating income change in % 37.23 4.74 -53.37 - -67.81 243.60 -21.52
Income before tax -6.06 -9.77 -10.68 -6.36 -1.19 0.70 1.18
Income before tax change in % 37.96 8.45 -67.73 -432.92 - -40.83 -24.99
Income after tax -6.07 -13.74 -8.66 -4.56 -1.21 0.56 0.91
Income after tax change in % 55.85 -58.65 -89.82 -276.45 - -38.02 -16.15

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019 2018
Total liabilities 11.64 8.11 11.01 4.79 3.76 2.65 1.58
Long-term liabilities per share 0.10 0.08 0.09 0.00 0.00 0.01 0.00
Equity 16.81 20.35 31.33 36.50 36.16 11.24 8.96
Equity change in % -17.39 -35.03 -14.18 0.95 221.79 25.39 16.83
Balance sheet total 28.45 28.46 42.33 41.29 39.92 13.88 10.55
Balance sheet total change in % -0.02 -32.77 2.52 3.44 187.56 31.64 13.62

Key Data in USD

2024 2023 2022 2021 2020 2019 2018
Sales per share 0.73 0.63 0.62 0.53 0.58 0.59 0.45
P/E ratio (year end quote, basic EPS) - - - - - 453.47 70.51
P/E ratio (year end quote, diluted EPS) - - - - - 453.47 70.51
Dividend yield in % 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity ratio in % 59.09 71.51 74.00 88.40 90.58 80.94 84.98
Debt ratio in % 40.91 28.49 26.00 11.60 9.42 19.06 15.02

Repro Medical System Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Manko Joseph M. Jr. 05/19/2025 14,317.00 5,863,230.00 n/a Sell No
Tharby Linda M 04/20/2025 23,587.00 1,023,163.00 2.20 Sell No
Matin Shahriar 04/01/2025 5,870.00 83,415.00 2.56 Buy No
French Donna 04/01/2025 5,870.00 80,785.00 2.56 Buy No
FLETCHER R JOHN 04/01/2025 8,806.00 205,562.00 2.56 Buy No
CASCELLA ROBERT 04/01/2025 5,870.00 80,426.00 2.56 Buy No
Tharby Linda M 03/18/2025 29,813.00 1,046,750.00 2.83 Sell No
Pazdan Christopher 03/18/2025 12,849.00 71,625.00 2.83 Sell No
Pazdan Christopher 03/18/2025 36,331.00 84,474.00 n/a Buy No
Miller Kenneth E 03/16/2025 2,168.00 3,725.00 2.89 Sell No
Tharby Linda M 03/16/2025 8,848.00 1,076,563.00 2.89 Sell No
Adams Thomas Edward 03/16/2025 1,988.00 3,416.00 2.89 Sell No
Pazdan Christopher 03/16/2025 1,641.00 48,143.00 2.89 Sell No
Miller Kenneth E 03/16/2025 5,893.00 5,893.00 n/a Buy No
Tharby Linda M 03/16/2025 15,968.00 1,085,411.00 n/a Buy No
Adams Thomas Edward 03/16/2025 5,404.00 5,404.00 n/a Buy No
Pazdan Christopher 03/16/2025 5,063.00 49,784.00 n/a Buy No
Manko Joseph M. Jr. 02/05/2025 16,187.00 5,871,677.00 n/a Sell No
Manko Joseph M. Jr. 01/20/2025 1,000,000.00 n/a n/a Sell No
Manko Joseph M. Jr. 01/20/2025 1,000,000.00 5,887,864.00 n/a Sell No
Manko Joseph M. Jr. 01/20/2025 1,000,000.00 1,000,000.00 n/a Buy No
Manko Joseph M. Jr. 01/20/2025 351,948.00 517,200.00 n/a Buy No
Matin Shahriar 01/02/2025 3,937.00 77,545.00 3.81 Buy No
WHOLIHAN EDWARD 01/02/2025 3,937.00 27,713.00 3.81 Buy No
Manko Joseph M. Jr. 12/30/2024 3,937.00 6,887,864.00 n/a Buy No

Repro Medical System Dividend Calendar

Date Name Dividend *yield Currency
2024 Repro Medical System IncShs 0.00 0.00 USD
2023 Repro Medical System IncShs 0.00 0.00 USD
2022 Repro Medical System IncShs 0.00 0.00 USD
2021 Repro Medical System IncShs 0.00 0.00 USD
2020 Repro Medical System IncShs 0.00 0.00 USD
2019 Repro Medical System IncShs 0.00 0.00 USD
2018 Repro Medical System IncShs 0.00 0.00 USD
2017 Repro Medical System IncShs 0.00 0.00 USD
2016 Repro Medical System IncShs 0.00 0.00 USD
2015 Repro Medical System IncShs 0.00 0.00 USD
2014 Repro Medical System IncShs 0.00 0.00 USD
2013 Repro Medical System IncShs 0.00 0.00 USD
2012 Repro Medical System IncShs 0.00 0.00 USD
2011 Repro Medical System IncShs 0.00 0.00 USD
2010 Repro Medical System IncShs 0.00 0.00 USD
2009 Repro Medical System IncShs 0.00 0.00 USD
*Yield of the Respective Date

Repro Medical System Calendar

Event Estimate Info Date
Earnings Report -0.022 USD Q2 2025 Earnings Release 08/06/2025
Earnings Report -0.016 USD Q3 2025 Earnings Release 11/05/2025
Earnings Report -0.014 USD Q4 2025 Earnings Release 03/04/2026
Earnings Report -0.010 USD Q1 2026 Earnings Release 05/13/2026

Repro Medical System Past Events

Event Actual EPS Info Date
Annual General Meeting -0.130 USD Annual General Meeting 05/14/2025
Earnings Report -0.030 USD Q1 2025 Earnings Release 05/07/2025
Earnings Report -0.030 USD Q4 2024 Earnings Release 03/12/2025
Earnings Report -0.030 USD Q3 2024 Earnings Release 11/13/2024
Earnings Report -0.020 USD Q2 2024 Earnings Release 08/07/2024
Annual General Meeting -0.300 USD Annual General Meeting 05/09/2024
Earnings Report -0.040 USD Q1 2024 Earnings Release 05/01/2024
Earnings Report -0.160 USD Q4 2023 Earnings Release 03/13/2024
Earnings Report -0.030 USD Q3 2023 Earnings Release 11/08/2023
Earnings Report -0.050 USD Q2 2023 Earnings Release 08/09/2023
Annual General Meeting -0.190 USD Annual General Meeting 05/17/2023
Earnings Report -0.050 USD Q1 2023 Earnings Release 05/04/2023
Earnings Report -0.040 USD Q4 2022 Earnings Release 03/08/2023
Earnings Report -0.030 USD Q3 2022 Earnings Release 11/09/2022
Earnings Report -0.070 USD Q2 2022 Earnings Release 08/03/2022
Annual General Meeting -0.100 USD Annual General Meeting 05/06/2022
Earnings Report -0.060 USD Q1 2022 Earnings Release 05/04/2022
Earnings Report -0.020 USD Q4 2021 Earnings Release 03/02/2022

Repro Medical System Profile

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
5
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.
OSZAR »